<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id><journal-id journal-id-type="iso-abbrev">BMC Musculoskelet Disord</journal-id><journal-title-group><journal-title>BMC Musculoskeletal Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2474</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23802771</article-id><article-id pub-id-type="pmc">3700815</article-id><article-id pub-id-type="publisher-id">1471-2474-14-195</article-id><article-id pub-id-type="doi">10.1186/1471-2474-14-195</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Effects of the carrier frequency of interferential current on pain modulation in patients with chronic nonspecific low back pain: a protocol of a randomised controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Corrêa</surname><given-names>Juliana Barbosa</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>julianabcorrea@gmail.com</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Costa</surname><given-names>Leonardo Oliveira Pena</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lcos3060@gmail.com</email></contrib><contrib contrib-type="author" id="A3"><name><surname>de Oliveira</surname><given-names>Naiane Teixeira Bastos</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>naiateixeira@hotmail.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Sluka</surname><given-names>Kathleen A</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>kathleen-sluka@uiowa.edu</email></contrib><contrib contrib-type="author" corresp="yes" id="A5"><name><surname>Liebano</surname><given-names>Richard Eloin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>liebano@gmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Master’s and Doctoral Programs in Physical Therapy, Universidade Cidade de São Paulo (UNICID), São Paulo, Brazil</aff><aff id="I2"><label>2</label>Graduate Program in Physical Therapy and Rehabilitation Science, University of Iowa, College of Medicine, Iowa City, IA, USA</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>27</day><month>6</month><year>2013</year></pub-date><volume>14</volume><fpage>195</fpage><lpage>195</lpage><history><date date-type="received"><day>25</day><month>3</month><year>2013</year></date><date date-type="accepted"><day>21</day><month>6</month><year>2013</year></date></history><permissions><copyright-statement>Copyright © 2013 Corrêa et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Corrêa et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2474/14/195"></self-uri><abstract><sec><title><offsets xml_i="3750" xml_f="3760" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3771" xml_f="4107" txt_i="22" txt_f="358">Low back pain is an important public health problem that is associated with poor quality of life and disability. Among the electrophysical treatments, interferential current (IFC) has not been studied in patients with low back pain in a high-quality randomised controlled trial examining not only pain, but pain mechanisms and function.</offsets></p></sec><sec><title><offsets xml_i="4129" xml_f="4143" txt_i="360" txt_f="374">Methods/design</offsets></title><p><offsets xml_i="4154" xml_f="4570" txt_i="375" txt_f="791">A three-arm randomised controlled trial with patient and assessor blinded to the group allocation. One hundred fifty patients with chronic, nonspecific low back pain from outpatient physical therapy clinics in Brazil. The patients will be randomly allocated into 3 groups (IFC 1 kHz, IFC 4 kHz or Placebo IFC). The interferential current will be applied three days per week (30 minutes per session) over four weeks. </offsets><italic><offsets xml_i="4578" xml_f="4593" txt_i="791" txt_f="806">Primary outcome</offsets></italic><offsets xml_i="4602" xml_f="4620" txt_i="806" txt_f="824">: Pain intensity. </offsets><italic><offsets xml_i="4628" xml_f="4646" txt_i="824" txt_f="842">Secondary outcomes</offsets></italic><offsets xml_i="4655" xml_f="5013" txt_i="842" txt_f="1200">: The pressure pain threshold, global impression of recovery, disability, function, conditioned pain modulation and temporal summation of pain, discomfort caused by the current. All outcomes will be measured at 4 weeks and 4 months after randomisation. The between-group differences will be calculated by using linear mixed models and Tukey’s post-hoc tests.</offsets></p></sec><sec><title><offsets xml_i="5035" xml_f="5045" txt_i="1202" txt_f="1212">Discussion</offsets></title><p><offsets xml_i="5056" xml_f="5263" txt_i="1213" txt_f="1420">The use of a placebo group and double-blinding assessor and patients strengthen this study. The present study is the first to compare different IFC carrier frequencies in patients with chronic low back pain.</offsets></p></sec><sec><title><offsets xml_i="5285" xml_f="5303" txt_i="1422" txt_f="1440">Trial registration</offsets></title><p><offsets xml_i="5314" xml_f="5353" txt_i="1441" txt_f="1480">Brazilian Registry of Clinical Trials: </offsets><ext-link ext-link-type="uri" xlink:href="http://RBR-8n4hg2"><offsets xml_i="5414" xml_f="5431" txt_i="1480" txt_f="1497">http://RBR-8n4hg2</offsets></ext-link></p></sec></abstract><kwd-group><kwd>Low Back Pain</kwd><kwd>Electric Stimulation</kwd><kwd>Central Nervous System Sensitization</kwd><kwd>Central Sensitization</kwd><kwd>Physical Therapy Modalities</kwd></kwd-group></article-meta></front><body><sec><title><offsets xml_i="5699" xml_f="5709" txt_i="1506" txt_f="1516">Background</offsets></title><p><offsets xml_i="5720" xml_f="5863" txt_i="1517" txt_f="1660">Low back pain is an important public health issue that directly affects an individual’s quality of life and activities of daily living (ADLs) [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="5894" xml_f="5895" txt_i="1660" txt_f="1661">1</offsets></xref><offsets xml_i="5902" xml_f="6011" txt_i="1661" txt_f="1770">]. Low back pain is also responsible for many absences from work and has high worldwide socioeconomic costs [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6042" xml_f="6043" txt_i="1770" txt_f="1771">2</offsets></xref><offsets xml_i="6050" xml_f="6299" txt_i="1771" txt_f="2020">]. The prognosis with acute and persistent low back pain is favourable, and the condition improves or resolves in the majority within the first 6 weeks. However, low to moderate pain levels and disability can persist in patients who become chronic [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="6330" xml_f="6331" txt_i="2020" txt_f="2021">3</offsets></xref><offsets xml_i="6338" xml_f="6340" txt_i="2021" txt_f="2023">].</offsets></p><p><offsets xml_i="6347" xml_f="6469" txt_i="2024" txt_f="2146">Inefficient endogenous pain control and central sensitivity are important characteristics in patients with low back pain [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="6500" xml_f="6501" txt_i="2146" txt_f="2147">4</offsets></xref><offsets xml_i="6508" xml_f="6725" txt_i="2147" txt_f="2364">]. Prolonged afferent nociceptive impulses may lead to increased excitability of the central sensory neurons and changes in their plasticity that lead to hypersensitivity resulting in an exaggerated response to pain [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="6756" xml_f="6757" txt_i="2364" txt_f="2365">5</offsets></xref><offsets xml_i="6764" xml_f="7276" txt_i="2365" txt_f="2877">]. Increasing evidence supports the clinical significance of the central sensitisation in patients with unexplained chronic pain; therefore, reduction in central sensitisation should be targeted for the treatment of these patients. The use of conservative therapies such as transcutaneous electrical nerve stimulation (TENS) and manual therapy in experimental models suggests that these treatments can reduce the central sensitization in animals and could desensitise the central nervous system (CNS) in humans [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7307" xml_f="7308" txt_i="2877" txt_f="2878">6</offsets></xref><offsets xml_i="7315" xml_f="7316" txt_i="2878" txt_f="2879">,</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="7347" xml_f="7348" txt_i="2879" txt_f="2880">7</offsets></xref><offsets xml_i="7355" xml_f="7357" txt_i="2880" txt_f="2882">].</offsets></p><p><offsets xml_i="7364" xml_f="7439" txt_i="2883" txt_f="2958">The treatment of chronic low back pain aims to reduce pain and disability [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="7470" xml_f="7471" txt_i="2958" txt_f="2959">8</offsets></xref><offsets xml_i="7478" xml_f="7561" txt_i="2959" txt_f="3042">]. Exercise is widely prescribed for treating patients with chronic low back pain [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="7592" xml_f="7593" txt_i="3042" txt_f="3043">9</offsets></xref><offsets xml_i="7600" xml_f="7736" txt_i="3043" txt_f="3179">]. However, patients with low back pain may have significant pain that limits their physical capacity, making it difficult to exercise [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="7768" xml_f="7770" txt_i="3179" txt_f="3181">10</offsets></xref><offsets xml_i="7777" xml_f="7941" txt_i="3181" txt_f="3345">]. Therefore, the use of electrophysical agents to decrease pain could enable these patients to participate in an exercise program at an earlier stage of recovery [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="7973" xml_f="7975" txt_i="3345" txt_f="3347">10</offsets></xref><offsets xml_i="7982" xml_f="8101" txt_i="3347" txt_f="3466">]. Among the electrotherapeutical resources, interferential current (IFC) has been studied for the treatment of acute [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="8133" xml_f="8135" txt_i="3466" txt_f="3468">11</offsets></xref><offsets xml_i="8142" xml_f="8171" txt_i="3468" txt_f="3497">] and chronic low back pain [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="8203" xml_f="8205" txt_i="3497" txt_f="3499">10</offsets></xref><offsets xml_i="8212" xml_f="8476" txt_i="3499" txt_f="3763">]. A recent systematic review concluded that when combined with other treatments, such as exercises and massage, IFC demonstrates advantages over placebo and non-treatment control groups in reducing the intensity of pain associated with musculoskeletal disorders [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="8508" xml_f="8510" txt_i="3763" txt_f="3765">12</offsets></xref><offsets xml_i="8517" xml_f="8619" txt_i="3765" txt_f="3867">]. However, little evidence has indicated that the use of IFC alone can reduce the intensity of pain [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="8651" xml_f="8653" txt_i="3867" txt_f="3869">12</offsets></xref><offsets xml_i="8660" xml_f="8756" txt_i="3869" txt_f="3965">], disability or use of analgesics, or improve function in patients with chronic low back pain [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="8788" xml_f="8790" txt_i="3965" txt_f="3967">10</offsets></xref><offsets xml_i="8797" xml_f="8799" txt_i="3967" txt_f="3969">].</offsets></p><p><offsets xml_i="8806" xml_f="9041" txt_i="3970" txt_f="4205">Despite various adjustments to the amplitude-modulated frequency (AMF) often used in clinical practice to treat different injury or disease stages, studies have indicated that AMF does not influence hypoalgesia in healthy individuals [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="9073" xml_f="9075" txt_i="4205" txt_f="4207">13</offsets></xref><offsets xml_i="9082" xml_f="9083" txt_i="4207" txt_f="4208">,</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="9115" xml_f="9117" txt_i="4208" txt_f="4210">14</offsets></xref><offsets xml_i="9124" xml_f="9272" txt_i="4210" txt_f="4358">], which suggests that the main parameter that should be adjusted is the carrier frequency of the current to affect the pain inhibitory mechanisms [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="9304" xml_f="9306" txt_i="4358" txt_f="4360">13</offsets></xref><offsets xml_i="9313" xml_f="9523" txt_i="4360" txt_f="4570">]. A 2 kHz carrier frequency is often used to strengthen the muscles, and a 4 kHz frequency is used to produce analgesia. However, this conduct is based on therapists’ personal observations, equipment manuals [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="9555" xml_f="9557" txt_i="4570" txt_f="4572">15</offsets></xref><offsets xml_i="9564" xml_f="9613" txt_i="4572" txt_f="4621">] and not on controlled studies. Only one study [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="9645" xml_f="9647" txt_i="4621" txt_f="4623">16</offsets></xref><offsets xml_i="9654" xml_f="10682" txt_i="4623" txt_f="5651">] has compared the effect of the carrier frequencies of the interferential current on the pressure pain threshold in healthy individuals. This study demonstrated that a 1 kHz frequency provides a higher hypoalgesic response compared with 8 kHz or 10 kHz during and after IFC stimulation. However, the evidence on the use of IFC alone for decreasing pain remains insufficient. In addition, chronic low back pain appears to be linked to central sensitisation and a deficiency in the activation of the central pain inhibition mechanisms. Thus, these patients could possibly benefit from the use of IFC to relieve their symptoms. For these reasons, we decided to conduct a prospective randomized controlled study to assess the effects of IFC on pain at rest and during movement, and the disability in patients with chronic low back pain. This study also aims to assess if the use of IFC would reactivate the innate mechanism of conditioned pain modulation and decrease the central hypersensitivity in chronic low back pain patients.</offsets></p></sec><sec><title><offsets xml_i="10704" xml_f="10719" txt_i="5653" txt_f="5668">Methods /design</offsets></title><sec><title><offsets xml_i="10739" xml_f="10751" txt_i="5669" txt_f="5681">Study design</offsets></title><p><offsets xml_i="10762" xml_f="10876" txt_i="5682" txt_f="5796">This is a three-arm randomised controlled trial with patient and assessor blinded to the group allocation. Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="10906" xml_f="10907" txt_i="5796" txt_f="5797">1</offsets></xref><offsets xml_i="10914" xml_f="10949" txt_i="5797" txt_f="5832"> provides a flowchart of the study.</offsets></p><fig id="F1" position="float"><label><offsets xml_i="10990" xml_f="10998" txt_i="5833" txt_f="5841">Figure 1</offsets></label><caption><p><offsets xml_i="11018" xml_f="11041" txt_i="5841" txt_f="5864">Flowchart of the study.</offsets></p></caption><graphic xlink:href="1471-2474-14-195-1"></graphic></fig></sec><sec><title><offsets xml_i="11130" xml_f="11163" txt_i="5866" txt_f="5899">Participants, therapists, centres</offsets></title><p><offsets xml_i="11174" xml_f="11541" txt_i="5900" txt_f="6267">Patients seeking physical therapy treatment at the clinic of the Universidade Cidade de São Paulo - UNICID and the Centro de Especialidades Médicas de Guarulhos - CEMEG through medical referral who present nonspecific low back pain for at least 3 months and with a minimum pain intensity of 3 in the 0–10 pain numeric rating scale (NRS-Brazilian-Portuguese version) [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="11573" xml_f="11575" txt_i="6267" txt_f="6269">17</offsets></xref><offsets xml_i="11582" xml_f="12328" txt_i="6269" txt_f="7015">] during the last 7 days will be included in the study. Patients of both genders with ages ranging from 18 to 80 years old will be included. Patients with severe spinal disorders such as fractures, tumours and inflammatory diseases including ankylosing spondylitis; patients with nerve root disorders confirmed by neurological exams (herniated disks and spondylolisthesis with neurological involvement, spinal canal stenosis and others); patients suffering from neurological diseases, severe cardiopulmonary diseases, pregnancy, infection or skin lesions at the current application site, cancer, or changes in sensitivity and allergy in the region of electrode positioning; and patients who require artificial cardiac pacemakers will be excluded.</offsets></p><p><offsets xml_i="12335" xml_f="12765" txt_i="7016" txt_f="7446">Participants will be assessed by the researcher responsible for the assessments during the study to verify that they fit the inclusion criteria. If eligible, they will be informed of the study objectives. They will then sign an informed consent form to participate in the study. The present study was approved by the Research Ethics Committees of Universidade Cidade de São Paulo and Centro de Especialidades Médicas de Guarulhos.</offsets></p><p><offsets xml_i="12772" xml_f="13072" txt_i="7447" txt_f="7747">Due to the nature of the intervention, only the therapist responsible for application of IFC will be aware about group allocation; the assessor and the participants will be blinded to the group allocation. To keep the evaluator blind to the study groups, the device will be covered with a dark cloth.</offsets></p></sec><sec><title><offsets xml_i="13094" xml_f="13106" txt_i="7749" txt_f="7761">Intervention</offsets></title><p><offsets xml_i="13117" xml_f="13492" txt_i="7762" txt_f="8137">Each participant will be randomly allocated to one of 3 groups: Group IFC 1 kHz (n = 50), Group IFC 4 kHz (n = 50) and a Placebo IFC Group (n = 50). All participants will receive 30 minutes of current stimulation (the current amplitude will not be increased for the participants in the placebo group) 3 times per week on alternate days for 4 weeks for a total of 12 sessions.</offsets></p><p><offsets xml_i="13499" xml_f="14096" txt_i="8138" txt_f="8735">The present study will use the Neurovector equipment that produces a medium-frequency alternating current (Neurovector, Indústria Brasileira de Equipamentos Médicos - IBRAMED®, Amparo, Brazil). This equipment was developed exclusively for the present study and is not commercially available. The technique used will involve a bipolar mode with 2 channels located 5 cm from the L3 and L5 spinous processes. The following parameters will be employed: current carrier frequency according to the patient group (1 or 4 kHz); AMF = 100 Hz; Sweep = 50 Hz; 1:1 swing pattern and 30 minutes of stimulation.</offsets></p><p><offsets xml_i="14103" xml_f="14357" txt_i="8736" txt_f="8990">The procedures for the placebo group will be similar to those of the other groups; however, the current amplitude will not be increased. The patients will be informed that they may or may not feel any sensation at the application site of the electrodes [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="14389" xml_f="14391" txt_i="8990" txt_f="8992">13</offsets></xref><offsets xml_i="14398" xml_f="14892" txt_i="8992" txt_f="9486">]. For the active groups, the therapist will increase the current amplitude until the participant reports feeling a strong but comfortable tingling. Every 5 minutes, the therapist will ask each participant whether the “strong but comfortable tingling” remains. In case of sensory habituation, the current amplitude will be increased until the participant reaches the previous sensation. After ending the application, the patient will wait for 20 minutes for the necessary measurements be taken.</offsets></p></sec><sec><title><offsets xml_i="14914" xml_f="14930" txt_i="9488" txt_f="9504">Outcome measures</offsets></title><sec><title><offsets xml_i="14950" xml_f="14965" txt_i="9505" txt_f="9520">Primary outcome</offsets></title><p><offsets xml_i="14976" xml_f="15053" txt_i="9521" txt_f="9598">Pain intensity after all treatment sessions and 4 months after randomisation.</offsets></p></sec><sec><title><offsets xml_i="15075" xml_f="15093" txt_i="9600" txt_f="9618">Secondary outcomes</offsets></title><p><offsets xml_i="15104" xml_f="15347" txt_i="9619" txt_f="9862">(1) pressure pain threshold; (2) current discomfort; (3) disability; (4) global impression of recovery; (5) functional performance; (6) conditioned pain modulation and pain temporal summation; and (7) analgesic use measured in all time-points.</offsets></p></sec></sec><sec><title><offsets xml_i="15375" xml_f="15398" txt_i="9865" txt_f="9888">Measurement instruments</offsets></title><sec><title><offsets xml_i="15418" xml_f="15451" txt_i="9889" txt_f="9922">Pain numerical rating scale (NRS)</offsets></title><p><offsets xml_i="15462" xml_f="15539" txt_i="9923" txt_f="10000">Pain intensity will be assessed using the pain numerical rating scale (NRS) [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="15571" xml_f="15573" txt_i="10000" txt_f="10002">18</offsets></xref><offsets xml_i="15580" xml_f="15965" txt_i="10002" txt_f="10387">], which assesses the level of pain intensity perceived by the patient through an 11-point scale (ranging from 0 to 10), with 0 indicating “no pain” and 10 indicating the “worst possible pain”. The pain assessment will be carried out verbally with the patient reporting the pain intensity. This instrument has been translated and cross-culturally adapted for the Brazilian population [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="15997" xml_f="15999" txt_i="10387" txt_f="10389">17</offsets></xref><offsets xml_i="16006" xml_f="16008" txt_i="10389" txt_f="10391">].</offsets></p><p><offsets xml_i="16015" xml_f="16285" txt_i="10392" txt_f="10662">The pain will be assessed prior to applying the current, at 30 minutes of treatment with the current still on and 20 minutes after the current is turned off. This variable will be measured in all sessions, after treatment and in the follow-up examination after 4 months.</offsets></p></sec><sec><title><offsets xml_i="16307" xml_f="16336" txt_i="10664" txt_f="10693">Pressure pain threshold (PPT)</offsets></title><p><offsets xml_i="16347" xml_f="16563" txt_i="10694" txt_f="10910">The pressure pain threshold (PPT) will be measured using a Somedic digital pressure algometer (Somedic Inc., Hörby, Sweden). Assessments will be performed prior to application of the current, immediately after the 30</offsets><sup><offsets xml_i="16568" xml_f="16570" txt_i="10910" txt_f="10912">th</offsets></sup><offsets xml_i="16576" xml_f="16708" txt_i="10912" txt_f="11044"> minute of stimulation and 20 minutes after the session has ended. This assessment will be performed in the first and last sessions.</offsets></p><p><offsets xml_i="16715" xml_f="17008" txt_i="11045" txt_f="11338">Hygienisation with soap and water will be performed at the assessed sites. After cleaning the skin, the areas to which the algometer will be attached will be marked with a tape measure and a pen. Two points will be marked bilaterally: the first located 5 cm lateral to the L3 spinous process [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="17040" xml_f="17042" txt_i="11338" txt_f="11340">19</offsets></xref><offsets xml_i="17049" xml_f="17114" txt_i="11340" txt_f="11405">] and the second located 5 cm lateral to the L5 spinous process [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="17146" xml_f="17148" txt_i="11405" txt_f="11407">20</offsets></xref><offsets xml_i="17155" xml_f="17301" txt_i="11407" txt_f="11553">]. A point, to be used as a control, will also be marked on the tibialis anterior muscle of the right leg, 5 cm lateral to the tibial tuberosity [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="17333" xml_f="17335" txt_i="11553" txt_f="11555">21</offsets></xref><offsets xml_i="17342" xml_f="17344" txt_i="11555" txt_f="11557">].</offsets></p><p><offsets xml_i="17351" xml_f="17852" txt_i="11558" txt_f="12059">The assessor will conduct a preliminary study of intra-observer reliability for measuring the pressure pain threshold at the evaluation points that will be used in the study. Ten participants with chronic low back pain will be recruited and assessed on two occasions that are 48 hours apart. The intra-evaluator reliability for the measurement of the PPT will be estimated by calculating the intraclass correlation coefficients (ICC type 3,2) for the tibialis anterior muscle and the low back muscles.</offsets></p><p><offsets xml_i="17859" xml_f="17929" txt_i="12060" txt_f="12130">During the PPT measurements, the circular probe of the algometer (1-cm</offsets><sup><offsets xml_i="17934" xml_f="17935" txt_i="12130" txt_f="12131">2</offsets></sup><offsets xml_i="17941" xml_f="18032" txt_i="12131" txt_f="12222"> area) will be positioned perpendicular to the skin and pressed at approximately 50 kPa/s [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="18064" xml_f="18066" txt_i="12222" txt_f="12224">22</offsets></xref><offsets xml_i="18073" xml_f="18274" txt_i="12224" txt_f="12425">]. Participants will be asked to press a button when the pressure or discomfort sensation becomes clearly painful. Two pressure measurements (in kPa) will be collected from each area at 30-s intervals.</offsets></p><p><offsets xml_i="18281" xml_f="18568" txt_i="12426" txt_f="12713">Two demonstrations of the procedure will be conducted for each participant in the extensor muscles of the dominant forearm to ensure that the test is well-understood. The mean values will be used for the lumbar region and the tibialis anterior muscle in the pain threshold data analysis.</offsets></p></sec><sec><title><offsets xml_i="18590" xml_f="18608" txt_i="12715" txt_f="12733">Current discomfort</offsets></title><p><offsets xml_i="18619" xml_f="18819" txt_i="12734" txt_f="12934">The discomfort caused by the current will be assessed using a 10-cm visual analogue scale (VAS) where the far left end indicate “very comfortable” and the far right end indicate “very uncomfortable” [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="18851" xml_f="18853" txt_i="12934" txt_f="12936">23</offsets></xref><offsets xml_i="18860" xml_f="18940" txt_i="12936" txt_f="13016">]. The discomfort will be assessed at 30 minutes of stimulation in all sessions.</offsets></p></sec><sec><title><offsets xml_i="18962" xml_f="19000" txt_i="13018" txt_f="13056">Roland-Morris disability questionnaire</offsets></title><p><offsets xml_i="19011" xml_f="19175" txt_i="13057" txt_f="13221">Disability will be assessed by the Roland-Morris disability questionnaire, which is widely used to assess the functional performance associated with low back pain [</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="19207" xml_f="19209" txt_i="13221" txt_f="13223">24</offsets></xref><offsets xml_i="19216" xml_f="19321" txt_i="13223" txt_f="13328">]. This instrument, which has been translated and cross-culturally adapted for the Brazilian population [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="19353" xml_f="19355" txt_i="13328" txt_f="13330">25</offsets></xref><offsets xml_i="19362" xml_f="19832" txt_i="13330" txt_f="13800">], consists of 24 items that describe the daily activities that prove difficult for the patients to perform due to low back pain. Many of the selected items are directly correlated to a greater impairment in functional performance. The patients will be instructed to verbally state which items describe them on the particular assessment day. The questionnaire will be applied on the first and last days of treatment and at the 4-month follow-up (conducted by telephone).</offsets></p></sec><sec><title><offsets xml_i="19854" xml_f="19883" txt_i="13802" txt_f="13831">Global perceived effect scale</offsets></title><p><offsets xml_i="19894" xml_f="19988" txt_i="13832" txt_f="13926">The global impression of recovery will be assessed through the global perceived effect scale [</offsets><xref ref-type="bibr" rid="B26"><offsets xml_i="20020" xml_f="20022" txt_i="13926" txt_f="13928">26</offsets></xref><offsets xml_i="20029" xml_f="20030" txt_i="13928" txt_f="13929">,</offsets><xref ref-type="bibr" rid="B27"><offsets xml_i="20062" xml_f="20064" txt_i="13929" txt_f="13931">27</offsets></xref><offsets xml_i="20071" xml_f="20156" txt_i="13931" txt_f="14016">], which has been translated and cross-culturally adapted into Brazilian-Portuguese [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="20188" xml_f="20190" txt_i="14016" txt_f="14018">17</offsets></xref><offsets xml_i="20197" xml_f="20699" txt_i="14018" txt_f="14520">] and corresponds to an 11-point scale ranging from −5 points (much worse) to 0 (no change) to 5 points (completely recovered). To measure the global impression of recovery, the participants will be asked the following: “Compared with the beginning of the first episode, how would you currently describe your back?” Positive scores represent recovery, and negative scores indicate a worsening of the symptoms. The scale will be applied before and after treatment and at the 4-month telephone follow-up.</offsets></p></sec><sec><title><offsets xml_i="20721" xml_f="20738" txt_i="14522" txt_f="14539">Sit-to-stand test</offsets></title><p><offsets xml_i="20749" xml_f="20969" txt_i="14540" txt_f="14760">Functional performance will be assessed through a sit-to-stand test. The patients will be instructed to sit and stand 5 times from a chair with a backrest with their arms crossed in front of them as quickly as they can [</offsets><xref ref-type="bibr" rid="B28"><offsets xml_i="21001" xml_f="21003" txt_i="14760" txt_f="14762">28</offsets></xref><offsets xml_i="21010" xml_f="21304" txt_i="14762" txt_f="15056">]. The test will be timed, and immediately after the test, the patients will be questioned regarding the low back pain experienced during the test. The test will be performed during the first and last sessions prior to the application of the current and after 30 minutes of current stimulation.</offsets></p></sec><sec><title><offsets xml_i="21326" xml_f="21349" txt_i="15058" txt_f="15081">Pain temporal summation</offsets></title><p><offsets xml_i="21360" xml_f="21525" txt_i="15082" txt_f="15247">Temporal summation (TS) will be induced by an analogue pressure algometer (FPK20, Wagner Instruments, Greenwich, CT, USA) with a circular metal tip measuring 0.79 cm</offsets><sup><offsets xml_i="21530" xml_f="21531" txt_i="15247" txt_f="15248">2</offsets></sup><offsets xml_i="21537" xml_f="22315" txt_i="15248" txt_f="16026">. The evaluator will be trained prior to the data collection. The area selected for TS analysis will be the site indicated as the lower pain threshold in the low back algometry in which three stimuli per second will be applied with a pressure of approximately 2 kg/s to determine the best value for use in the TS test. Next, 10 stimuli will be performed using the algometer on the selected region. Each TS stimulus will be maintained for 1 second before being released, and the stimuli will be spaced at 1-second intervals. A timer will be used to ensure that the intervals are respected and that the stimuli are maintained. Participants will be instructed to report pain using the NRS, which will be posted on the wall in front of them, at the first, fifth and tenth stimulus [</offsets><xref ref-type="bibr" rid="B29"><offsets xml_i="22347" xml_f="22349" txt_i="16026" txt_f="16028">29</offsets></xref><offsets xml_i="22356" xml_f="22664" txt_i="16028" txt_f="16336">]. The TS assessment will be performed prior to initiating the treatment protocol and prior to current application during the last session. To prevent sensitisation interference from the previously performed pain pressure threshold assessment, the TS assessment will begin 2 minutes after the PPT assessment.</offsets></p></sec><sec><title><offsets xml_i="22686" xml_f="22713" txt_i="16338" txt_f="16365">Conditioned pain modulation</offsets></title><p><offsets xml_i="22724" xml_f="22824" txt_i="16366" txt_f="16466">A cold pressor test will be used to assess the activation of the conditioned pain modulation (CPM) [</offsets><xref ref-type="bibr" rid="B30"><offsets xml_i="22856" xml_f="22858" txt_i="16466" txt_f="16468">30</offsets></xref><offsets xml_i="22865" xml_f="23089" txt_i="16468" txt_f="16692">]. The conditioned stimulus will involve the immersion of the lower limb on the ipsilateral side of the more painful lumbar region. In cases of bilateral pain, the subject will be instructed to report the most painful side [</offsets><xref ref-type="bibr" rid="B31"><offsets xml_i="23121" xml_f="23123" txt_i="16692" txt_f="16694">31</offsets></xref><offsets xml_i="23130" xml_f="23897" txt_i="16694" txt_f="17461">]. If no consensus can be reached regarding the most painful side, the right leg will be used. The limb will be immersed in a bucket containing water and ice at 4°C, 3 cm above the lateral malleolus of the ankle. The low back pain intensity will be assessed after 20 seconds of immersion using the NRS. The PPT at the low-back algometry points will be recorded 30 seconds after immersion. After removing the limb from the water, the participants will be questioned regarding their foot pain according to the NRS. A CPM activation test will be performed on the first day of treatment prior to initiating the stimulation and on the last day of the session prior to applying the current so that no interference occurs in the CPM assessment immediately after stimulation.</offsets></p></sec><sec><title><offsets xml_i="23919" xml_f="23932" txt_i="17463" txt_f="17476">Analgesic use</offsets></title><p><offsets xml_i="23943" xml_f="24225" txt_i="17477" txt_f="17759">To assess the use of analgesics during the treatment, the assessor will complete a record listing the days of the week from the beginning of the treatment until the date of the last session to note the use of analgesics or anti-inflammatory drugs and their dosage during treatment [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="24257" xml_f="24259" txt_i="17759" txt_f="17761">10</offsets></xref><offsets xml_i="24266" xml_f="24365" txt_i="17761" txt_f="17860">]. With this information, any reduction in the use of medications during treatment can be assessed.</offsets></p></sec></sec><sec><title><offsets xml_i="24393" xml_f="24402" txt_i="17863" txt_f="17872">Procedure</offsets></title><sec><title><offsets xml_i="24422" xml_f="24435" txt_i="17873" txt_f="17886">Randomisation</offsets></title><p><offsets xml_i="24446" xml_f="25217" txt_i="17887" txt_f="18658">After assessment, the patients will be referred to the therapist responsible for the treatment, who will open the sealed envelope prior to initiating the treatment to determine in which group the patient will be included (Group IFC 1 kHz, Group IFC 4 kHz or the IFC Placebo Group). The randomisation of groups will be performed using a computer-generated, random-number list compiled by an investigator not involved in the patient recruitment or data collection. The group allocation will be concealed by printing the group allocation onto cards and sealing them in consecutively numbered opaque envelopes. The envelopes will be stored in a secure cabinet accessibly only to the allocation investigator and will be opened immediately prior to the intervention allocation.</offsets></p></sec><sec><title><offsets xml_i="25239" xml_f="25264" txt_i="18660" txt_f="18685">Study-blinding assessment</offsets></title><p><offsets xml_i="25275" xml_f="25650" txt_i="18686" txt_f="19061">Following the treatment and the follow-up assessments, the therapist will ask the assessor if she believes that the patient received interferential current or the placebo. Additionally, the study participants will answer the same questions justifying their answers. The answers to these questions will be recorded and used to measure the effectiveness of the study blinding [</offsets><xref ref-type="bibr" rid="B32"><offsets xml_i="25682" xml_f="25684" txt_i="19061" txt_f="19063">32</offsets></xref><offsets xml_i="25691" xml_f="25693" txt_i="19063" txt_f="19065">].</offsets></p></sec><sec><title><offsets xml_i="25715" xml_f="25728" txt_i="19067" txt_f="19080">Data analysis</offsets></title><p><offsets xml_i="25739" xml_f="26498" txt_i="19081" txt_f="19837">Data will be double-entered and analysis will be performed by a blinded statistician. All statistical procedures will be conducted following the intention-to-treat principles. Initially, the descriptive statistics will be used for the studied variables. The data normalisation will be analysed through a visual inspection of the histograms. The between-group differences in the measurements of the primary and secondary outcomes will be compared via linear mixed models using the interaction terms “group versus time” with a Tukey’s post-hoc test. For the data analysis, the SPSS (statistical package for social sciences) version 19.0 for Windows and Microsoft Excel 2007 will be used. All tests will be performed assuming a significance level of p &lt; 0.05.</offsets></p></sec><sec><title><offsets xml_i="26520" xml_f="26543" txt_i="19839" txt_f="19862">Sample size calculation</offsets></title><p><offsets xml_i="26554" xml_f="26824" txt_i="19863" txt_f="20133">To obtain the total number of participants in the present study, the sample size was calculated to detect a difference of 1 point in the pain intensity outcome as measured by the numerical rating scale (NRS) (Costa et al. 2008) with a standard deviation of 1.47 points [</offsets><xref ref-type="bibr" rid="B33"><offsets xml_i="26856" xml_f="26858" txt_i="20133" txt_f="20135">33</offsets></xref><offsets xml_i="26865" xml_f="27065" txt_i="20135" txt_f="20335">]. A statistical power of 80%, a 5% alpha and a possible sample loss of up to 15% were considered. Therefore, 50 patients per group (150 in total) will be required (Minitab, v. 15, State College, PA).</offsets></p></sec></sec></sec><sec sec-type="discussion"><title><offsets xml_i="27121" xml_f="27131" txt_i="20339" txt_f="20349">Discussion</offsets></title><p><offsets xml_i="27142" xml_f="27325" txt_i="20350" txt_f="20533">The results of the present study will provide more accurate estimates of the therapeutic effects and parameters of interferential currents. The last systematic review on the subject [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="27357" xml_f="27359" txt_i="20533" txt_f="20535">12</offsets></xref><offsets xml_i="27366" xml_f="28057" txt_i="20535" txt_f="21226">] suggests that new studies need to be performed given the lack of high-quality research on the use of interferential current in patients with low back pain. This study can also provide information on the effects of the current on the pain mechanisms and the optimum carrier frequency for use in the analgesia of chronic, nonspecific low back pain. The results of the present study may also assist physical therapists in making clinical decisions based on a high-quality randomised controlled trial. An appropriate choice of therapy can increase the efficacy of low back pain treatments, thereby increasing patients’ satisfaction and reducing the social costs associated with these patients.</offsets></p><p><offsets xml_i="28064" xml_f="28550" txt_i="21227" txt_f="21713">The strengths of the present study include a high quality design that supports strong clinical evidence. The use of a placebo group enables an analysis of the therapy’s effectiveness and aids in understanding the placebo effect. The study’s blinding assessment indicates the reliability of the assessor and patient blinding. The present study is the first to compare different IFC carrier frequencies in patients suffering from pain and to assess the long-term effects of the treatment.</offsets></p><p><offsets xml_i="28557" xml_f="28777" txt_i="21714" txt_f="21934">The study’s limitations include the impossibility of completely blinding the therapist due to the nature of the intervention and the lack of a control group (undergoing no treatment) for comparison with the other groups.</offsets></p></sec><sec><title><offsets xml_i="28799" xml_f="28812" txt_i="21936" txt_f="21949">Abbreviations</offsets></title><p><offsets xml_i="28823" xml_f="29186" txt_i="21950" txt_f="22313">ADLs: Activities of daily living; TENS: Transcutaneous electrical nerve stimulation; CNS: Central nervous system; IFC: Interferential current; AMF: Amplitude-modulated frequency; NRS: Numeric rating scale; PPT: Pressure pain threshold; ICC: Intraclass correlation coefficients; VAS: Visual analogue scale; TS: Temporal summation; CPM: Conditioned pain modulation.</offsets></p></sec><sec><title><offsets xml_i="29208" xml_f="29227" txt_i="22315" txt_f="22334">Competing interests</offsets></title><p><offsets xml_i="29238" xml_f="29427" txt_i="22335" txt_f="22524">We certify that no party with a direct interest in the results of the research supporting this article has or will confer benefits on us or on any organisation with which we are associated.</offsets></p></sec><sec><title><offsets xml_i="29449" xml_f="29471" txt_i="22526" txt_f="22548">Authors’ contributions</offsets></title><p><offsets xml_i="29482" xml_f="29723" txt_i="22549" txt_f="22790">JBC, REL, LOPC and KAS were responsible for conceiving and designing the study. REL and LPOC are the study coordinators. JBC and NTBO are responsible for data collection. All authors have contributed for writing and approved this manuscript.</offsets></p></sec><sec><title><offsets xml_i="29745" xml_f="29768" txt_i="22792" txt_f="22815">Pre-publication history</offsets></title><p><offsets xml_i="29779" xml_f="29843" txt_i="22816" txt_f="22880">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/14/195/prepub"><offsets xml_i="29946" xml_f="29998" txt_i="22881" txt_f="22933">http://www.biomedcentral.com/1471-2474/14/195/prepub</offsets></ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>The authors thank the financial support obtained from Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Brazil; funder approval number: 2012/13910-2 and from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil; funder approval number: 473929/2012-0.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Koldas Dogan</surname><given-names>S</given-names></name><name><surname>Sonel Tur</surname><given-names>B</given-names></name><name><surname>Kurtais</surname><given-names>Y</given-names></name><name><surname>Atay</surname><given-names>MB</given-names></name><article-title>Comparison of three different approaches in the treatment of chronic low backpain</article-title><source>Clin Rheumatol</source><year>2008</year><volume>27</volume><fpage>873</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">18188660</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Delitto</surname><given-names>A</given-names></name><name><surname>George</surname><given-names>SZ</given-names></name><name><surname>Van Dillen</surname><given-names>LR</given-names></name><name><surname>Whitman</surname><given-names>JM</given-names></name><name><surname>Sowa</surname><given-names>G</given-names></name><name><surname>Shekelle</surname><given-names>P</given-names></name><name><surname>Denninger</surname><given-names>TR</given-names></name><name><surname>Godges</surname><given-names>JJ</given-names></name><article-title>Low back pain</article-title><source>J Orthop Sports Phys Ther</source><year>2012</year><volume>42</volume><fpage>A1</fpage><lpage>A57</lpage><pub-id pub-id-type="pmid">22466247</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Costa</surname><given-names>LO</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Hancock</surname><given-names>MJ</given-names></name><name><surname>McAuley</surname><given-names>JH</given-names></name><name><surname>Herbert</surname><given-names>RD</given-names></name><name><surname>Costa</surname><given-names>LO</given-names></name><article-title>The prognosis of acute and persistent low-back pain: a meta-analysis</article-title><source>CMAJ</source><year>2012</year><volume>184</volume><fpage>E613</fpage><lpage>E624</lpage><pub-id pub-id-type="pmid">22586331</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Staud</surname><given-names>R</given-names></name><article-title>Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia</article-title><source>Curr Rheumatol Rep</source><year>2011</year><volume>13</volume><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">21833699</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Salter</surname><given-names>MW</given-names></name><article-title>Neuronal plasticity: increasing the gain in pain</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>1765</fpage><lpage>1769</lpage><pub-id pub-id-type="pmid">10846153</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>YT</given-names></name><name><surname>Sluka</surname><given-names>KA</given-names></name><article-title>Reduction in inflammation-induced sensitization of dorsal horn neurons by transcutaneous electrical nerve stimulation in anesthetized rats</article-title><source>Exp Brain Res</source><year>2001</year><volume>137</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">11310176</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Nijs</surname><given-names>J</given-names></name><name><surname>Meeus</surname><given-names>M</given-names></name><name><surname>Van Oosterwijck</surname><given-names>J</given-names></name><name><surname>Roussel</surname><given-names>N</given-names></name><name><surname>De Kooning</surname><given-names>M</given-names></name><name><surname>Ickmans</surname><given-names>K</given-names></name><name><surname>Matic</surname><given-names>M</given-names></name><article-title>Treatment of central sensitization in patients with ‘‘unexplained” chronic pain: what options do we have?</article-title><source>Expert Opin Pharmacother</source><year>2011</year><volume>12</volume><fpage>1087</fpage><lpage>1098</lpage><pub-id pub-id-type="pmid">21254866</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>De Rosa</surname><given-names>CP</given-names></name><name><surname>Porterfield</surname><given-names>JA</given-names></name><article-title>A physical therapy model for the treatment of low back pain</article-title><source>Phys Ther</source><year>1992</year><volume>72</volume><fpage>261</fpage><lpage>269</lpage><comment>discussion 270–262</comment><pub-id pub-id-type="pmid">1533940</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Airaksinen</surname><given-names>O</given-names></name><name><surname>Brox</surname><given-names>JI</given-names></name><name><surname>Cedraschi</surname><given-names>C</given-names></name><name><surname>Hildebrandt</surname><given-names>J</given-names></name><name><surname>Klaber-Moffett</surname><given-names>J</given-names></name><name><surname>Kovacs</surname><given-names>F</given-names></name><name><surname>Mannion</surname><given-names>AF</given-names></name><name><surname>Reis</surname><given-names>S</given-names></name><name><surname>Staal</surname><given-names>JB</given-names></name><name><surname>Ursin</surname><given-names>H</given-names></name><name><surname>Zanoli</surname><given-names>G</given-names></name><article-title>Chapter 4. European guidelines for the management of chronic nonspecific low back pain</article-title><source>Eur Spine J</source><year>2006</year><volume>15</volume><issue>Suppl 2</issue><fpage>S192</fpage><lpage>S300</lpage><pub-id pub-id-type="pmid">16550448</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Facci</surname><given-names>LM</given-names></name><name><surname>Nowotny</surname><given-names>JP</given-names></name><name><surname>Tormem</surname><given-names>F</given-names></name><name><surname>Trevisani</surname><given-names>VF</given-names></name><article-title>Effects of transcutaneous electrical nerve stimulation (TENS) and interferential currents (IFC) in patients with nonspecific chronic low back pain: randomized clinical trial</article-title><source>Sao Paulo Med J</source><year>2011</year><volume>129</volume><fpage>206</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">21971895</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Hurley</surname><given-names>DA</given-names></name><name><surname>McDonough</surname><given-names>SM</given-names></name><name><surname>Dempster</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>AP</given-names></name><name><surname>Baxter</surname><given-names>GD</given-names></name><article-title>A randomized clinical trial of manipulative therapy and interferential therapy for acute low back pain</article-title><source>Spine (Phila Pa 1976)</source><year>2004</year><volume>29</volume><fpage>2207</fpage><lpage>2216</lpage><pub-id pub-id-type="pmid">15480130</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Fuentes</surname><given-names>JP</given-names></name><name><surname>Armijo Olivo</surname><given-names>S</given-names></name><name><surname>Magee</surname><given-names>DJ</given-names></name><name><surname>Gross</surname><given-names>DP</given-names></name><article-title>Effectiveness of interferential current therapy in the management of musculoskeletal pain: a systematic review and meta-analysis</article-title><source>Phys Ther</source><year>2010</year><volume>90</volume><fpage>1219</fpage><lpage>1238</lpage><pub-id pub-id-type="pmid">20651012</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Dounavi</surname><given-names>MD</given-names></name><name><surname>Chesterton</surname><given-names>LS</given-names></name><name><surname>Sim</surname><given-names>J</given-names></name><article-title>Effects of interferential therapy parameter combinations upon experimentally induced pain in pain-free participants: a randomized controlled trial</article-title><source>Phys Ther</source><year>2012</year><volume>92</volume><fpage>911</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">22491480</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Fuentes</surname><given-names>CJ</given-names></name><name><surname>Armijo-Olivo</surname><given-names>S</given-names></name><name><surname>Magee</surname><given-names>DJ</given-names></name><name><surname>Gross</surname><given-names>D</given-names></name><article-title>Does amplitude-modulated frequency have a role in the hypoalgesic response of interferential current on pressure pain sensitivity in healthy subjects? A randomised crossover study</article-title><source>Physiotherapy</source><year>2010</year><volume>96</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">20113759</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="book"><name><surname>Hogenkamp</surname><given-names>M</given-names></name><name><surname>Mittelmeijer</surname><given-names>E</given-names></name><name><surname>Smits</surname><given-names>I</given-names></name><name><surname>Stralen</surname><given-names>CV</given-names></name><source>Interferential therapy: Therapy Manual</source><year>2005</year><publisher-name>Netherlands: Enraf-Nonius B. V</publisher-name><fpage>1</fpage><lpage>27</lpage></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Venancio</surname><given-names>RC</given-names></name><name><surname>Pelegrini</surname><given-names>S</given-names></name><name><surname>Gomes</surname><given-names>DQ</given-names></name><name><surname>Nakano</surname><given-names>EY</given-names></name><name><surname>Liebano</surname><given-names>RE</given-names></name><article-title>Effects of carrier frequency of interferential current on pressure pain threshold and sensory comfort in humans</article-title><source>Arch Phys Med Rehabil</source><year>2013</year><volume>94</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">22922327</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Costa</surname><given-names>LO</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Latimer</surname><given-names>J</given-names></name><name><surname>Ferreira</surname><given-names>PH</given-names></name><name><surname>Ferreira</surname><given-names>ML</given-names></name><name><surname>Pozzi</surname><given-names>GC</given-names></name><name><surname>Freitas</surname><given-names>LM</given-names></name><article-title>Clinimetric testing of three self-report outcome measures for low back pain patients in Brazil: which one is the best?</article-title><source>Spine (Phila Pa 1976)</source><year>2008</year><volume>33</volume><fpage>2459</fpage><lpage>2463</lpage><pub-id pub-id-type="pmid">18923324</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="book"><name><surname>Turk</surname><given-names>D</given-names></name><name><surname>Melzack</surname><given-names>R</given-names></name><source>Handbook of Pain Assessment</source><year>1992</year><publisher-name>New York: The Guilford Press</publisher-name></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Meeus</surname><given-names>M</given-names></name><name><surname>Roussel</surname><given-names>NA</given-names></name><name><surname>Truijen</surname><given-names>S</given-names></name><name><surname>Nijs</surname><given-names>J</given-names></name><article-title>Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study</article-title><source>J Rehabil Med</source><year>2010</year><volume>42</volume><fpage>884</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">20878051</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Schenk</surname><given-names>P</given-names></name><name><surname>Laeubli</surname><given-names>T</given-names></name><name><surname>Klipstein</surname><given-names>A</given-names></name><article-title>Validity of pressure pain thresholds in female workers with and without recurrent low back pain</article-title><source>Eur Spine J</source><year>2007</year><volume>16</volume><fpage>267</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">16680447</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>O’Neill</surname><given-names>S</given-names></name><name><surname>Kjaer</surname><given-names>P</given-names></name><name><surname>Graven-Nielsen</surname><given-names>T</given-names></name><name><surname>Manniche</surname><given-names>C</given-names></name><name><surname>Arendt-Nielsen</surname><given-names>L</given-names></name><article-title>Low pressure pain thresholds are associated with, but does not predispose for, low back pain</article-title><source>Eur Spine J</source><year>2011</year><volume>20</volume><fpage>2120</fpage><lpage>2125</lpage><pub-id pub-id-type="pmid">21512842</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Liebano</surname><given-names>RE</given-names></name><name><surname>Rakel</surname><given-names>B</given-names></name><name><surname>Vance</surname><given-names>CG</given-names></name><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Sluka</surname><given-names>KA</given-names></name><article-title>An investigation of the development of analgesic tolerance to TENS in humans</article-title><source>Pain</source><year>2011</year><volume>152</volume><fpage>335</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">21144659</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Barr</surname><given-names>JO</given-names></name><name><surname>Weissenbuehler</surname><given-names>SA</given-names></name><name><surname>Cleary</surname><given-names>CK</given-names></name><article-title>Effectiveness and Comfort of Transcutaneous Electrical Nerve Stimulation for Older Persons withChronic Pain</article-title><source>J Geriatr Phys Ther</source><year>2004</year><volume>3</volume><fpage>93</fpage><lpage>99</lpage></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Roland</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>R</given-names></name><article-title>A study of the natural history of low-back pain. Part II: development of guidelines for trials of treatment in primary care</article-title><source>Spine (Phila Pa 1976)</source><year>1983</year><volume>8</volume><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">6222487</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Nusbaum</surname><given-names>L</given-names></name><name><surname>Natour</surname><given-names>J</given-names></name><name><surname>Ferraz</surname><given-names>MB</given-names></name><name><surname>Goldenberg</surname><given-names>J</given-names></name><article-title>Translation, adaptation and validation of the Roland-Morris questionnaire–Brazil Roland-Morris</article-title><source>Braz J Med Biol Res</source><year>2001</year><volume>34</volume><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">11175495</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="book"><name><surname>Feinstein</surname><given-names>A</given-names></name><source>Clinimetrics</source><year>1987</year><publisher-name>New Haven: Yale University Press</publisher-name></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Kamper</surname><given-names>SJ</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Mackay</surname><given-names>G</given-names></name><article-title>Global rating of change scales: a review of strengths and weaknesses and considerations for design</article-title><source>J Man Manip Ther</source><year>2009</year><volume>17</volume><fpage>163</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">20046623</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Simmonds</surname><given-names>MJ</given-names></name><name><surname>Olson</surname><given-names>SL</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Hussein</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Novy</surname><given-names>D</given-names></name><name><surname>Radwan</surname><given-names>H</given-names></name><article-title>Psychometric characteristics and clinical usefulness of physical performance tests in patients with low back pain</article-title><source>Spine (Phila Pa 1976)</source><year>1998</year><volume>23</volume><fpage>2412</fpage><lpage>2421</lpage><pub-id pub-id-type="pmid">9836355</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Cathcart</surname><given-names>S</given-names></name><name><surname>Winefield</surname><given-names>AH</given-names></name><name><surname>Rolan</surname><given-names>P</given-names></name><name><surname>Lushington</surname><given-names>K</given-names></name><article-title>Reliability of temporal summation and diffuse noxious inhibitory control</article-title><source>Pain Res Manag</source><year>2009</year><volume>14</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">20011713</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Knudsen</surname><given-names>L</given-names></name><name><surname>Drummond</surname><given-names>PD</given-names></name><article-title>Cold-induced limb pain decreases sensitivity to pressure-pain sensations in the ipsilateral forehead</article-title><source>Eur J Pain</source><year>2009</year><volume>13</volume><fpage>1023</fpage><lpage>1029</lpage><pub-id pub-id-type="pmid">19171493</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Neziri</surname><given-names>AY</given-names></name><name><surname>Dickenmann</surname><given-names>M</given-names></name><name><surname>Scaramozzino</surname><given-names>P</given-names></name><name><surname>Andersen</surname><given-names>OK</given-names></name><name><surname>Arendt-Nielsen</surname><given-names>L</given-names></name><name><surname>Dickenson</surname><given-names>AH</given-names></name><name><surname>Curatolo</surname><given-names>M</given-names></name><article-title>Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients</article-title><source>Pain</source><year>2012</year><volume>153</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">22100357</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Rakel</surname><given-names>B</given-names></name><name><surname>Cooper</surname><given-names>N</given-names></name><name><surname>Adams</surname><given-names>HJ</given-names></name><name><surname>Messer</surname><given-names>BR</given-names></name><name><surname>Frey Law</surname><given-names>LA</given-names></name><name><surname>Dannen</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Polehna</surname><given-names>AC</given-names></name><name><surname>Ruggle</surname><given-names>RC</given-names></name><name><surname>Vance</surname><given-names>CG</given-names></name><etal></etal><article-title>A new transient sham TENS device allows for investigator blinding while delivering a true placebo treatment</article-title><source>J Pain</source><year>2010</year><volume>11</volume><fpage>230</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">19945354</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Werners</surname><given-names>R</given-names></name><name><surname>Pynsent</surname><given-names>PB</given-names></name><name><surname>Bulstrode</surname><given-names>CJ</given-names></name><article-title>Randomized trial comparing interferential therapy with motorized lumbar traction and massage in the management of low back pain in a primary care setting</article-title><source>Spine (Phila Pa 1976)</source><year>1999</year><volume>24</volume><fpage>1579</fpage><lpage>1584</lpage><pub-id pub-id-type="pmid">10457578</pub-id></mixed-citation></ref></ref-list></back></article>